(19)
(11) EP 3 624 810 A1

(12)

(43) Date of publication:
25.03.2020 Bulletin 2020/13

(21) Application number: 18803111.6

(22) Date of filing: 17.05.2018
(51) International Patent Classification (IPC): 
A61K 31/7115(2006.01)
A61K 47/50(2017.01)
A61K 31/7125(2006.01)
(86) International application number:
PCT/US2018/033265
(87) International publication number:
WO 2018/213631 (22.11.2018 Gazette 2018/47)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.05.2017 US 201762507996 P
05.01.2018 US 201862614325 P

(71) Applicant: The Regents of the University of California
Oakland, CA 94607 (US)

(72) Inventors:
  • NEL, E. Andre
    Sherman Oaks, California 91423 (US)
  • MENG, Huan
    Los Angeles, California 90034 (US)
  • LU, Jianqin
    Los Angeles, California 90034 (US)

(74) Representative: Mewburn Ellis LLP 
City Tower 40 Basinghall Street
London EC2V 5DE
London EC2V 5DE (GB)

   


(54) NANO-ENABLED IMMUNOTHERAPY IN CANCER